Profusa Lumee PAD study meets primary endpoints in U.S. trial
Profusa (Nasdaq: PFSA) presented FDA-advised pilot phase results at Paris Vascular Insights on…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…
ORIC Pharmaceuticals to Present Enozertinib Data at ESMO Asia 2025
ORIC Pharmaceuticals (Nasdaq: ORIC) announced two late-breaking oral presentations of…
Common antidepressant helps reduce some men’s domestic violence, ReINVEST trial finds
What if a common antidepressant could help stop some angry, impulsive men from committing domestic violence? That question…
‘I Cry Every Time I Talk About It’ (Exclusive)
NEED TO KNOW Jaclyn Hayes Lin was 32 weeks pregnant when she was diagnosed with stage 4 pancreatic…
After 1- and 6-Month Gains, Gene Editing Companies Await Q3 Results
As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Opus Genetics, Inc. Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
Dengue infection leaves lasting genetic imprint on immunity
Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the…
Texas Children’s successfully treats AADC deficiency using FDA-approved gene therapy
Texas Children’s is pleased to announce that a three-year-old girl has been successfully treated with the first-ever FDA-approved…
Scientists map the genes behind diet and dementia risk
Scientists reveal a new genetic resource from the MIND diet trial, opening the door to precision nutrition strategies…
AI spots hidden diabetes risk even when test results look normal
Millions may be missing early diabetes risk. AI models show why your blood sugar spikes might matter more…